» Articles » PMID: 21247746

Recommendations for the Use of Cardiovascular Tests in Diagnosing Diabetic Autonomic Neuropathy

Overview
Publisher Elsevier
Date 2011 Jan 21
PMID 21247746
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Despite its prevalence, clinical and prognostic impact, diabetic autonomic neuropathy, is widely under-diagnosed. The need for training and expertise to perform the cardiovascular tests (usually the task of diabetologists) is one possible reason. The availability of computer-assisted systems has allowed a wider diffusion of testing, but has also highlighted the need for an adequate knowledge of physiopathological backgrounds for their correct application and interpretation. The recommendations presented here were developed by the Neuropathy Study Group of the Italian Society of Diabetology and then endorsed by the Italian Association for the Study of Neurovegetative System, to promote the widespread adoption of good clinical practice in diabetic cardiovascular autonomic testing by outlining main evidence-based aspects, i.e. which tests, how to perform them, adequate interpretation of the results and their diagnostic use, confounding conditions that can impact on tests reliability. Therefore, these recommendations include the essential aspects of the physiopathological substrate of the tests, the controversial points in their analysis, their diagnostic characteristics, as well as safety. Detailed information is given on the physiological (age, weight, body position, resting heart rate and blood pressure, respiratory pattern, exercise, meals, acute blood glucose changes) and pathophysiological confounding factors, with emphasis on the effects of drugs. Instructions on how to perform the tests and interpret their results are also considered together with indications of candidate patients and periodicity of testing. A patient instruction sheet on why and how to perform the tests is included. Finally, the specific requirements for computerized systems to perform and evaluate cardiovascular tests are provided.

Citing Articles

Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not in type 2 diabetes.

Risi R, Amendolara R, Pantano A, Fassino V, DOnofrio L, Coraggio L Cardiovasc Diabetol. 2025; 24(1):74.

PMID: 39953513 PMC: 11829334. DOI: 10.1186/s12933-025-02635-6.


Effect of exercise training on cardiac autonomic function in type 2 diabetes mellitus: a systematic review and meta-analysis.

Raje S, Maiya G, R P, Prabhu M, Nayak K, Kn S Syst Rev. 2025; 14(1):34.

PMID: 39905568 PMC: 11792330. DOI: 10.1186/s13643-025-02772-9.


Transcutaneous vagus nerve stimulation has no anti-inflammatory effect in diabetes.

Okdahl T, Kufaishi H, Kornum D, Bertoli D, Krogh K, Knop F Sci Rep. 2024; 14(1):21042.

PMID: 39251831 PMC: 11385211. DOI: 10.1038/s41598-024-72139-y.


Composite Autonomic Symptom Score-31 for the diagnosis of cardiovascular autonomic dysfunction in long-term coronavirus disease 2019.

Yar T, Salem A, Rafique N, Latif R, Siddiqui I, Shaikh M J Family Community Med. 2024; 31(3):214-221.

PMID: 39176014 PMC: 11338387. DOI: 10.4103/jfcm.jfcm_20_24.


Baroreflex Sensitivity as a Surrogate Biomarker for Concurrently Assessing the Severity of Arterial Stiffness and Cardiovascular Autonomic Neuropathy in Individuals with Type 2 Diabetes.

Hsieh D, Lai Y, Huang C, Chen Y, Wu S, Chiu W J Pers Med. 2024; 14(5).

PMID: 38793073 PMC: 11122369. DOI: 10.3390/jpm14050491.